1. Tuli, H.S., V. Aggarwal, M. Tuorkey, D. Aggarwal and N.C. Parashar et al., 2021. Emodin: A metabolite that exhibits anti-neoplastic activities by modulating multiple oncogenic targets. Toxicol. In Vitro, Vol. 73. 10.1016/j.tiv.2021.105142.
   CrossRef  |  Direct Link  |  
2. Tuli, H.S., S. Mittal, D. Aggarwal, G. Parashar and N.C. Parashar et al., 2021. Path of Silibinin from diet to medicine: A dietary polyphenolic flavonoid having potential anti-cancer therapeutic significance. Semin. Cancer Biol., 73: 196-218.
   CrossRef  |  Direct Link  |  
3. Thawkar, B.S. and G. Kaur, 2021. Zebrafish as a promising tool for modeling neurotoxin-induced Alzheimer’s disease. Neurotoxic. Res., 39: 949-965.
   CrossRef  |  Direct Link  |  
4. Chaudhari, V., H.S. Buttar, S. Bagwe-Parab, H.S. Tuli, A. Vora and G. Kaur, 2021. Therapeutic and industrial applications of Curdlan with overview on its recent patents. Front. Nutr., Vol. 8. 10.3389/fnut.2021.646988.
   CrossRef  |  Direct Link  |  
5. Kumawat, V.S. and G. Kaur, 2020. Insulinotropic and antidiabetic effects of β-caryophyllene with L-arginine in type 2 diabetic rats. J. Food Biochem., Vol. 44. 10.1111/jfbc.13156.
   CrossRef  |  Direct Link  |  
6. Bagwe-Parab, S., P. Yadav, G. Kaur, H.S. Tuli and H.S. Buttar, 2020. Therapeutic applications of human and bovine colostrum in the treatment of gastrointestinal diseases and distinctive cancer types: The current evidence. Front. Pharmacol., Vol. 11. 10.3389/fphar.2020.01100.
   CrossRef  |  Direct Link  |  
7. Bagwe-Parab, S. and G. Kaur, 2020. Molecular targets and therapeutic interventions for iron induced neurodegeneration. Brain Res. Bull., 156: 1-9.
   CrossRef  |  Direct Link  |  
8. Aggarwal, V., H.S. Tuli, J. Kaur, D. Aggarwal and G. Parashar et al., 2020. Garcinol exhibits anti-neoplastic effects by targeting diverse oncogenic factors in tumor cells. Biomedicines, Vol. 8. 10.3390/biomedicines8050103.
   CrossRef  |  Direct Link  |  
9. Kumawat, V.S. and G. Kaur, 2019. Therapeutic potential of cannabinoid receptor 2 in the treatment of diabetes mellitus and its complications. Eur. J. Pharmacol., Vol. 862. 10.1016/j.ejphar.2019.172628.
   CrossRef  |  Direct Link  |  
10. Karri, S., S. Sharma and G. Kaur, 2019. Pharmacological and analytical aspects of artemisinin for malaria: Advances and challenges. Asian Pac. J. Trop. Med., 12: 339-346.
    CrossRef  |  Direct Link  |  
11. Bhullar, S.K., D.G. Ruzgar, G. Fortunato, G.K. Aneja and M. Orhan et al., 2019. A facile method for controlled fabrication of hybrid silver nanoparticle-poly (-caprolactone) fibrous constructs with antimicrobial properties. J. Nanosci. Nanotechnol., 19: 6949-6955.
    CrossRef  |  Direct Link  |  
12. Thawkar, B.S. and G. Kaur, 2018. Inhibitors of NF-κB and P2X7/NLRP3/Caspase 1 pathway in microglia: Novel therapeutic opportunities in neuroinflammation induced early-stage Alzheimer’s disease. J. Neuroimmunol., 326: 62-74.
    CrossRef  |  Direct Link  |  
13. Kaur, G., M. Invally, M.K. Khan and P. Jadhav, 2018. A nutraceutical combination of Cinnamomum cassia & Nigella sativa for Type 1 diabetes mellitus. J. Ayurveda Integr. Med., 9: 27-37.
    CrossRef  |  Direct Link  |  
14. Kaur, G., L.J.P. Tharappel and V. Kumawat, 2018. Evaluation of safety and in vitro mechanisms of anti-diabetic activity of β-caryophyllene and l-arginine. J. Biol. Sci., 18: 124-134.
    CrossRef  |  Direct Link  |  
15. Kaur, G., B. Thawkar, S. Dubey and P. Jadhav, 2018. Pharmacological potentials of betalains. J. Comp. Integr. Med., 15: 1-9.
16. Jain, S., H.S. Buttar, M. Chintameneni and G. Kaur, 2018. Prevention of cardiovascular diseases with anti-inflammatory and anti- oxidant nutraceuticals and herbal products: an overview of pre-clinical and clinical studies. Recent Pat. Inflamm. Allergy Drug. Discov., 12: 145-157.
    CrossRef  |  Direct Link  |  
17. Godbole, R., M. Invally, S. Wairkar, S. Bhullar and G. Kaur, 2018. Formulation, development and evaluation of a novel polymer-based anti-inflammatory emulgel of aceclofenac. Sci. Int., 6: 71-79.
    CrossRef  |  Direct Link  |  
18. Kulkarni, A.Y., K.H. Barve and G. Kaur, 2017. Natural Products as an Effective Treatment Option for Depression. In: Herbs for Diabetes and Neurological Disease Management: Research and Advancements, Kumar, V. and A. Veeranjaneyulu, (Ed.). Apple Academic Press, USA, PP: 225-250.
19. Kaur, G., H. Sankrityayan, D. Dixitm and P. Jadhav, 2017. Cocos nucifera in combination with metformin for modulation of diabetic symptoms in streptozotocin induced diabetic rats. J. Ayurveda integ. Med., 10.1016/j.jaim.2017.02.006.
    CrossRef  |  Direct Link  |  
20. Invally, M., G. Kaur, S. Bhullar and H.S. Buttar, 2017. Health care burden of cardiorespiratory diseases caused by particulate matter and chemical air pollutants. World Heart J., 9: 303-317.
21. Invally, M., G. Kaur and H.S. Buttar, 2017. Evaluation of the antidepressant activity of beta vulgaris alone and in combination with fluoxetine in mice. J. Pharmacol. Toxicol., 12: 33-41.
    CrossRef  |  Direct Link  |  
22. Ingle-Jadhav, P., T.R. Angolkar and G. Kaur, 2017. Diabetes and Phytopharmaceuticals:Translational Pharmacology Perspective. In: Herbs for Diabetes and Neurological Disease Management: Research and Advancements, Kumar, V. and A. Veeranjaneyulu (Ed.). Apple Academic Press, USA, pp: 201-223.
23. Buttar, H.S., S.M. Bagwe, S.K. Bhullar and G. Kaur, 2017. Health Benefits of Bovine Colostrum in Children and Adults in Dairy. In: Human Health and Disease Across the Lifespan, Watson, R., R.J. Collier and V. Preedy (Eds.). Academic Press, Nigeria, ISBN: 9780128098684, pp: 3-20.
24. Yadav, R., T. Angolkar, G. Kaur and H.S Buttar, 2016. Antibacterial and antiinflammatory properties of bovine colostrum. Recent Patents Inflammat. Allergy Drug Discovery, 10: 49-53.
    Direct Link  |  
25. Nayak, B.N., G. Kaur and H.S. Buttar, 2016. TNF-α modulation by natural bioactive molecules in mouse RAW 264.7 macrophage cells. J. Complement. Integrat. Med., 13: 1-7.
26. Kaur, G., P.D.H. Mistry and S. Bhullar, 2016. Drugs and Treatment Strategies Empowering Bone Fracture: Future of Bone Healing. LAP LAMBERT Academic Publishing, Germany.
27. Kaur, G., M. Invally and M. Chintamaneni, 2016. Influence of piperine and quercetin on antidiabetic potential of curcumin. J. Complement. Integr. Med., 13: 247-255.
28. Kaur, G. and H.S. Buttar, 2016. Potential adverse interactions between allopathic drugs, herbals and dietary products: Mechanisms of action and clinical implications. J. Diabetes Metab. Disord, Vol. 3. .
29. Bhullar, S.K., H.P. Singh, G. Kaur and H.S. Bhuttar, 2016. An overview of the application of nanomaterials and development of stents in cardiovascular disease. Adv. Mater. Sci. J., 44: 286-296.
30. Bhullar, S.K., D. Rana, B.K. Ozsel, R. Yadav and G. Kaur et al., 2016. A comparative study of the antibacterial activity of rosemary extract blended with polymeric biomaterials. J. Bionanosci., 10: 326-330.
    Direct Link  |  
31. Yadav, R., G. Kaur and M. Chintamaneni, 2015. Influence of curcumin on the synthetic drug amoxicillin. Sci. Int., 3: 64-68.
    CrossRef  |  Direct Link  |  
32. Tharappel, L.J., P. Patel, G. Kaur and V. Addepalli, 2015. Cervical cancer: A perspective on recent patents. Int. J. Cancer Res., 11: 159-163.
    CrossRef  |  Direct Link  |  
33. Somaiya, R. and G. Kaur, 2015. Future of Bone Repair. In: Bone and Tissue Regeneration Insights, Rolfe, K. (Ed.)., Libertas Academica, UK.
34. Patel, D.V., M.G. Sawant and G. Kaur, 2015. Evaluation of anti-osteoarthritic activity of Vigna mungo in papain induced osteoarthritis model. Indian J. Pharmacol., 47: 59-64.
    CrossRef  |  Direct Link  |  
35. Kaur, G., V. Wani, A. Dave and P. Jadhav, 2015. Effect of Lagenaria siceraria and Trigonella foenum graecum on lipid absorption and excretion for modulation of lipid profile. Sci. Int., 3: 18-24.
    CrossRef  |  Direct Link  |  
36. Kaur, G., S. Mukundan, V. Wani and M.S. Kumar, 2015. Nutraceuticals in the management and prevention of metabolic syndrome. Austin J. Pharmacol. Therapeut., Vol. 2. .
    Direct Link  |  
37. Kaur, G., R. Somaiya and S. Patel, 2015. Preventive and curative potential of Vigna mungo against metabolic syndrome in acute and chronic rat models. J. Biol. Sci., 15: 85-91.
    CrossRef  |  Direct Link  |  
38. Kaur, G., M. Invally, R. Sanzagiri and H.S. Buttar, 2015. Evaluation of the antidepressant activity of Moringa oleifera alone and in combination with fluoxetine. J. Ayurveda Integr. Med., 6: 273-279.
    PubMed  |  Direct Link  |  
39. Kaur, G. and H. Popli, 2015. Clinical trials industry in India. In: Pharmaceuticals, Cosmeceuticals and Nutraceuticals : An Overview of Regulation, Udupa, N. (Ed.). Career publications, Idia, ISBN: 10 8188739839, pp: 125-147.
40. Gandhi, P. and G. Kaur, 2015. Patient counselling: Encountering the role of pharmacist in managing patients with diabetes and related cardiovascular complications. Pharm. Pract. Theme Based Issue, 47: 25-28.
41. Bhullar, S.K., B.K. Ozsel, R. Yadav, G. Kaur, M. Chintamaneni and H.S. Buttar, 2015. Antibacterial activity of combination of synthetic and biopolymer non-woven structures. J. Complement. Integr. Med. 10.1515/jcim-2015-0027.
    CrossRef  |  Direct Link  |  
42. Barve, K.H., G. Kaur, A. Kumar and S. Daftardar, 2015. The effect of Murraya koenigii extract on therapeutic efficacy of amlodipine in rats: Possible drug-herb interaction. General Med., 3: 153-155.
43. Barve, K.H., G. Kaur, A. Kumar and S. Daftardar, 2015. The effect of Murraya koenigii extract on therapeutic efficacy of amlodipine in rats: Possible drug-herb interaction. Gen. Med., Vol. 3. 10.4172/2327-5146.1000153.
    CrossRef  |  Direct Link  |  
44. Bagwe, S., L.J. Tharappel, G. Kaur and H.S. Buttar, 2015. Bovine colostrum: An emerging nutraceutical. J. Complement. Integrat. Med., 12: 175-185.
45. Tharappel, L.J.P., G. Kaur and H.S. Buttar, 2014. Pharmaceutical education in India: Past, present and future. J. Pharm. Sci. Res., 6: 278-281.
    Direct Link  |  
46. Tharappel, L.J.P., G. Kaur and H.S. Buttar, 2014. India-a new contributor to the pharmacovigilance movement. Int. J. Pharmaceut. Sci. Res., 5: 3107-3122.
47. Sequerira, E., G. Kaur, M. Chintamaneni and H.S. Buttar, 2014. Lactose intolerance: Genetics of lactase polymorphisms, diagnosis and novel therapy. Biomed. Rev., 25: 35-44.
    Direct Link  |  
48. Kaur, G., S. Daftardar and K.H. Barve, 2014. Modifying anti-inflammatory effect of diclofenac with Murraya koenigii. Recent Patents Inflammat. Allergy Drug Discov., 8: 77-81.
    Direct Link  |  
49. Kaur, G., R. Somaiya, M. Wasim and H.S. Buttar, 2014. Cardioprotective effects of bovine colostrum against isoproterenol-induced myocardial infarction in rats. J. Pharmacol. Toxicol., 9: 37-45.
50. Daftardar, S., G. Kaur and V. Addepalli, 2014. Nutraceutical Approaches in the Management of Cardiovascular Dysfunctions Associated with Diabetes Mellitus. In: Diabetic Cardiomyopathy ,Biochemical and Molecular mechanism, Turan, B. and N.S. Dhalla (Eds.). Springer, New York, pp:3-25.
51. Patel, D., G. Kaur, M. Sawant and P. Deshmukh, 2013. Herbal medicine: A natural cure to arthritis. Indian J. Nat. Prod. Resour., 4: 27-35.
52. Nayadu, S., D. Behera, M. Sharma, G. Kaur and G. Gudi, 2013. Fluorescent probe based CYP inhibition assay: A high throughput tool for early drug discovery screening. Int. J. Pharm. Pharm. Sci., 5: 303-307.
53. Kaur, G., 2013. Polypharmacy: The past, present and the future. J. Adv. Pharm. Technol. Res., 4: 224-225.
    Direct Link  |  
54. Kaur, G. and C. Meena, 2013. Evaluation of anti-hyperlipidemic potential of combinatorial extract of curcumin, piperine and quercetin in Tritoninduced hyperlipidemia in rats. Sci. Int., 1: 57-63.
    Direct Link  |  
55. Geete, S.S., G. Kaur, R.K. Goyal and C. Pamnani, 2013. Emergence of resistance to fluoroquinolone utilized as second line treatment for tuberculosis. Indian J. Hospital Pharm., 50: 122-125.
56. Nayadu, S., G. Kaur, G. Gudi and V. Addepalli, 2012. The potentials of selected therapeutic targets for inflammation: A snapshot. Recent Patents Inflammat. Allergy Drug Discov., 6: 137-146.
    CrossRef  |  PubMed  |  
57. Mehta, A., G. Kaur and M. Chintamaneni, 2012. Piperine and quercetin enhances antioxidant and hepatoprotective effect of curcumin in paracetamol induced oxidative stress. Int. J. Pharmacol., 8: 101-107.
    CrossRef  |  Direct Link  |  
58. Kaur, G., U. Dave and K. Vadodaria, 2012. Simultaneous estimation of piperine, quercetin, and curcumin in a Mixture using U.V-visible spectrophotometer and method validation. Int. J. Therapeutic Applic., 8: 14-17.
59. Kaur, G. and C. Meena, 2012. Amelioration of obesity, glucose intolerance and oxidative stress in high-fat diet and low-dose streptozotocin-induced diabetic rats by combination consisting of curcumin with piperine and quercetin. ISRN Pharmacol., Vol. 2012. 10.5402/2012/957283.
    CrossRef  |  Direct Link  |  
60. Patel, A.G., G. Kaur and C. Meena, 2011. α-Glucosidase inhibitory activity of curcumin and its comparison with combinatorial extract consisting of curcumin with piperine and quercetin. Pharmacologyonline, 3: 796-801.
    Direct Link  |  
61. Kaur, G. and M. Chintamaneni, 2011. Curcumin: A Potential Drug Candidate. Lap Lambert Academic Publishing GmbH and Co., Saarbrucken, Germany, pp: 64.
62. Sharma, D., G. Kaur and M. Chintamaneni, 2010. Sjogren's syndrome: Recent advances in pathogenesis and pharmacotherapy. Pharmacology, 1: 523-533.
63. Poonia, M.K., G. Kaur, M. Chintamaneni and I. Changela, 2010. New insights into molecular targets for urinary incontinence. Indian J. Pharmacol., 42: 261-266.
    CrossRef  |  PubMed  |  Direct Link  |  
64. Kaur, G. and M. Chintamaneni, 2010. Antisense therapy for cancer-present and future prospects. Pharma Times, 42: 17-24.
65. Jain, S., G. Kaur and V.K. Jain, 2010. Intellectual property rights. J. Pharm. Sci. Res., 2: 314-316.
66. Kaur, G., R. Tuli and M. Chintamaneni, 2009. Antioxidant potential of methanolic and hydrolyzed extracts of Eclipta alba. Pharmacologyonline, 2: 947-956.
    Direct Link  |  
67. Kaur, G., M. Chintamaneni, V. Addepalli and S.S. Agrawal, 2009. Evaluation of hepatoprotective activity of Ocimum sanctum in HepG2 cell line. Arch. Pharm. Sci. Res., 1: 25-30.
68. Kaur, G. and M. Chintamaneni, 2009. Antinociceptive effects of combinatorial extract of curcumin-integration of traditional and modern concepts. The J. Clin. Pharmacol., 49: 1109-1109.
69. Asatha, R. Tuli, M. Chintamaneni and G. Kaur, 2009. Antioxidants-need of the hour!. Pharmacology, 206: 650-677.